3/8/22 - Module 1: Commitment to DEI

March 8, 2022

Commitment to DEI will describe the grounds for institutional and individual commitment to diversity, equity, and inclusion in clinical research, and illustrate how to substantiate commitment with actions, metrics, and resources.

Target Audience

This activity is intended for professionals and staff, leadership, and administration involved in Medical Oncology and Hematology with particular relevance to clinical research. The audience includes investigators, practicing providers, clinical trialists, clinical trials office staff, nurse practitioners, nurses, research nurse specialists, physician assistants, clinical research coordinators, and other frontline staff; Regulatory/IRB committee members, and others with basic experience conducting clinical trials.

Learning Objectives

Upon completion of this activity, participants will be able to: 

  1. Appreciate the background and context of DEI.
  2. Understand the importance of institutional commitment to DEI in clinical research
  3. Consider measures to evaluate progress on institutional commitment to DEI in clinical research.
  4. Learn to substantiate a statement of commitment.
  5. Identify roles of members of the clinical research community to support commitments with actions and resources.

Additional Information

Provided by: 

The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center and Mass General Brigham

Please Note:

While attendees are strongly encouraged to attend the live instruction and discussion sessions for each module, attendees may access a pre-recorded version of the instruction session through this learning platform one day before the live instruction and discussion sessions. Each discussion session will also be recorded and posted to this learning platform one day following the live presentation. All recordings will be accessible until one week following the live presentation of Module 6.

For questions or assistance with any special needs regarding the training series, please contact the MRCT Center at:  MRCT@bwh.harvard.edu

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Course opens: 
01/14/2022
Course expires: 
05/13/2022
Event starts: 
03/08/2022 - 4:30pm EST
Event ends: 
03/08/2022 - 6:00pm EST
Cost:
$0.00
Part of: 
Equity by Design in Clinical Research: Cancer Trials
Add to calendar: 
Rating: 
0

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 1.50  AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.